| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 753221 | 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline | 0.0110679092462694 | 0.38541496 |
| NSC 753222 | 3-Hydroxy-5,6-dihydro-6-imino-8,9-dimethylisoindolo-[2,1-a]quinoxaline | 0.0110679092462694 | 0.16608756 |
| NSC 75382 | Thiophene, tetrahydro-3,4-dibromo-, 1,1-dioxide | 0.0110679092462694 | 0.4094215 |
| NSC 754385 | 1-[bis(4,4'-aminophenyl)methylidenyl]-[3]ferrocenophane | 0.0110679092462694 | 0.20437407 |
| NSC 761676 | Null | 0.0110679092462694 | 0.33571603 |
| NSC 80103 | 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) | 0.0110679092462694 | 0.36114137 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0110679092462696 | 0.13417124 |
| NSC 160121 | 1H,5H-Benzo[ij]quinolizine, 2,3,6,7-tetrahydro-9-(octylamino)-, dihydrochloride | 0.0110679092462696 | 0.42490964 |
| NSC 265211 | NSC 265211 | 0.0110679092462696 | 0.056044405 |
| NSC 287459 | Cytarabine AY | 0.0110679092462696 | 0.35515335 |